Seward moves to new premises

Published: 3-Feb-2011
Manufacturing Active Nutrition Food

Doubles manufacturing and storage facilities

Seward Ltd, the manufacturer and developer of the Stomacher laboratory paddle blender range, has moved to new premises in Worthing, UK, which will double the firm’s manufacturing and storage facilities.

The new building represents a significant investment by the company following the securing of a NatWest/RBS Manufacturing Fund. It will also ensure shorter lead times for the Stomacher sample preparation products for microbiological analyses and tissue processing, the company said.

The premises also house a purpose-built r&d laboratory for product development, application assessment and customer protocol development.

Further investment in web conferencing facilities will also allow training webinars and in-depth technical support to be offered to customers, wherever they are located.

The new premises support a much-needed increase in production capacity, driven by new applications and the opening of Seward Inc in Long Island, New York, US in 2009.

In the first half of 2010, sales of the Stomacher laboratory blenders grew by nearly 20%, compared with the same period in 2009. Sales of the Stomacher 80 biomaster range for small tissue processing increased by 53%, while the large volume Stomacher 3500 saw a 72% growth.

‘We are dedicated to maintaining excellence in our products, customer service and support for our rapidly growing global customer base, so the increased size and capacity of our new premises ensures we can guarantee this now and in the future,’ said Stuart Ray, technical director, Seward Ltd.

He added that the firm had also seen strong growth in the US and Asia/Pacific regions.

See more

You may also like

Manufacturing

Seward simplifies cell preparation

Read more
Enhances applications for Strainer bags to include sterile processing of tissue samples

Trending Articles

  1. Compact, economical and sustainable cooling solutions for laboratories Huber Unichillers offer space-saving and environmentally friendly temperature control for research and industrial applications
  2. Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
  3. Bruker announces major strides in 4D proteomics performance, further advances In intact and top-down functional proteoform analysis, and innovations in hybrid qual/quant 4D metabolomics All to enable deeper insights into disease biology. Bruker Also Launches Two Novel Mass Spectrometry Systems for Unique Applications in Energy Industry Research, and in Semiconductor Manufacturing
  4. CEPI fast-tracks three Bundibugyo ebolavirus vaccine candidates amid DRC outbreak With no licensed vaccines available and more than 900 suspected cases already recorded, CEPI is urgently advancing mRNA, rVSV and viral vector candidates from Moderna, IAVI and Oxford/SII toward clinical trials
  5. FDA Form 483 flags falsified records and live bird infestation at Dabur India OTC plant A FDA inspection report issued in January 2026 has revealed widespread CGMP failures at Dabur India's Dadra and Nagar Haveli facility, including manipulated microbiology data, fraudulent equipment logs and unsanitary storage conditions

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all

You may also like

Manufacturing

Seward simplifies cell preparation

Enhances applications for Strainer bags to include sterile processing of tissue samples
Manufacturing

Lonza appoints Hans Trees as Global Head of Communications

Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing

AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn

AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Manufacturing

Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing

Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration

CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
Manufacturing

Cutting-edge wiped film evaporator installation – non-tobacco nicotine products

Successful system installation for a UK research and development facility developing and commercialising non-tobacco nicotine products using industry-leading evaporation equipment
Manufacturing

Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe

After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to meet European market demand for pharmaceutical ampoules. Facility brings around 180 new jobs to the region
Subscribe now